Mirum Pharmaceuticals (NASDAQ:MIRM) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Mirum Pharmaceuticals beat estimated earnings by 12.69%, reporting an EPS of $-1.17 versus an estimate of $-1.34.
Revenue was up $12.89 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $1.99 which was followed by a 3.9% drop in the share price the next day.
Here's a look at Mirum Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.34 | -1.73 | -0.69 | |
| EPS Actual | -1.65 | -1.55 | -1.45 | 1.68 |
| Revenue Estimate | 62.65M | 830.00K | 14.50M | 8.33M |
| Revenue Actual | 3.14M | 5.00M | 11.00M | 0 |
To track all earnings releases for Mirum Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
